Insurers Receive Orders to Cover Coronavirus Antibody Tests

With the Trump administration anxious to “reopen” the U.S. economy and ease the social-distancing measures meant to slow the spread of COVID-19, officials have pointed to antibody testing as a critical tool to accomplish those goals. To that end, the administration on April 11 issued a document clarifying that most private health plans must cover such tests, which detect antibodies against the new coronavirus found in the blood of people who have been infected and now may be immune.

Experts tell AIS Health that the requirement to cover antibody (also known as serological) testing wasn’t entirely unexpected, but it does raise a host of still- unanswered questions, such as how much these tests will cost, how widely available they’ll be, and whether they can be relied upon.

0 Comments
© 2021 MMIT

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_321525828.jpg
November 24

‘Long COVID’ Presents Big Challenges for Health Plans, Patients

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-Pathway-or-Perish-The-Two-Pronged-Hurdle-to-Ensuring-Access-in-Oncology.jpg
November 24

Insurers Applaud New CMMI Push for Risk-Based Contracting

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_176559451.jpg
November 24

Non-Emergent 911 Calls Offer Intervention Opportunity

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today